SARS-CoV-2 infection among hospitalised pregnant women and impact of different viral strains on COVID-19 severity in Italy: a national prospective population-based cohort study
- PMID: 34687585
- PMCID: PMC8652503
- DOI: 10.1111/1471-0528.16980
SARS-CoV-2 infection among hospitalised pregnant women and impact of different viral strains on COVID-19 severity in Italy: a national prospective population-based cohort study
Abstract
Objective: The primary aim of this article was to describe SARS-CoV-2 infection among pregnant women during the wild-type and Alpha-variant periods in Italy. The secondary aim was to compare the impact of the virus variants on the severity of maternal and perinatal outcomes.
Design: National population-based prospective cohort study.
Setting: A total of 315 Italian maternity hospitals.
Sample: A cohort of 3306 women with SARS-CoV-2 infection confirmed within 7 days of hospital admission.
Methods: Cases were prospectively reported by trained clinicians for each participating maternity unit. Data were described by univariate and multivariate analyses.
Main outcome measures: COVID-19 pneumonia, ventilatory support, intensive care unit (ICU) admission, mode of delivery, preterm birth, stillbirth, and maternal and neonatal mortality.
Results: We found that 64.3% of the cohort was asymptomatic, 12.8% developed COVID-19 pneumonia and 3.3% required ventilatory support and/or ICU admission. Maternal age of 30-34 years (OR 1.43, 95% CI 1.09-1.87) and ≥35 years (OR 1.62, 95% CI 1.23-2.13), citizenship of countries with high migration pressure (OR 1.75, 95% CI 1.36-2.25), previous comorbidities (OR 1.49, 95% CI 1.13-1.98) and obesity (OR 1.72, 95% CI 1.29-2.27) were all associated with a higher occurrence of pneumonia. The preterm birth rate was 11.1%. In comparison with the pre-pandemic period, stillbirths and maternal and neonatal deaths remained stable. The need for ventilatory support and/or ICU admission among women with pneumonia increased during the Alpha-variant period compared with the wild-type period (OR 3.24, 95% CI 1.99-5.28).
Conclusions: Our results are consistent with a low risk of severe COVID-19 disease among pregnant women and with rare adverse perinatal outcomes. During the Alpha-variant period there was a significant increase of severe COVID-19 illness. Further research is needed to describe the impact of different SARS-CoV-2 viral strains on maternal and perinatal outcomes.
Keywords: COVID-19 pneumonia; Cohort studies; Italy; SARS-CoV-2; pregnancy.
© 2021 John Wiley & Sons Ltd.
Figures
Comment in
-
SARS-CoV-2 infection among hospitalised pregnant women and impact of different viral strains on COVID-19 disease severity in Italy.BJOG. 2022 Jan;129(2):232. doi: 10.1111/1471-0528.16981. Epub 2021 Nov 11. BJOG. 2022. PMID: 34687262 Free PMC article.
Similar articles
-
Clinical and epidemiological aspects of SARS-CoV-2 infection among pregnant and postpartum women in Mozambique: a prospective cohort study.Reprod Health. 2022 Jul 19;19(1):164. doi: 10.1186/s12978-022-01469-9. Reprod Health. 2022. PMID: 35854384 Free PMC article.
-
SARS-CoV-2 and pregnancy outcomes under universal and non-universal testing in Sweden: register-based nationwide cohort study.BJOG. 2022 Jan;129(2):282-290. doi: 10.1111/1471-0528.16990. Epub 2021 Nov 18. BJOG. 2022. PMID: 34706148 Free PMC article.
-
Association of Maternal Perinatal SARS-CoV-2 Infection With Neonatal Outcomes During the COVID-19 Pandemic in Massachusetts.JAMA Netw Open. 2021 Apr 1;4(4):e217523. doi: 10.1001/jamanetworkopen.2021.7523. JAMA Netw Open. 2021. PMID: 33890989 Free PMC article.
-
Clinical manifestations, risk factors, and maternal and perinatal outcomes of coronavirus disease 2019 in pregnancy: living systematic review and meta-analysis.BMJ. 2020 Sep 1;370:m3320. doi: 10.1136/bmj.m3320. BMJ. 2020. Update in: BMJ. 2022 May 30;377:o1205. doi: 10.1136/bmj.o1205. PMID: 32873575 Free PMC article. Updated.
-
An update on COVID-19 and pregnancy.Am J Obstet Gynecol. 2022 Feb;226(2):177-186. doi: 10.1016/j.ajog.2021.08.054. Epub 2021 Sep 14. Am J Obstet Gynecol. 2022. PMID: 34534497 Free PMC article. Review.
Cited by
-
COVID-19 in Pregnancy: Knowledge about the Vaccine and the Effect of the Virus. Reliability and Results of the MAMA-19 Questionnaire.Int J Environ Res Public Health. 2022 Nov 12;19(22):14886. doi: 10.3390/ijerph192214886. Int J Environ Res Public Health. 2022. PMID: 36429605 Free PMC article. Review.
-
Fetal death after the introduction of COVID-19 mitigation measures in Sweden, Denmark and Norway: a registry-based study.Sci Rep. 2022 Nov 30;12(1):20625. doi: 10.1038/s41598-022-25036-1. Sci Rep. 2022. PMID: 36450919 Free PMC article.
-
Severe COVID-19 in pregnancy is almost exclusively limited to unvaccinated women - time for policies to change.Lancet Reg Health Eur. 2022 Feb;13:100313. doi: 10.1016/j.lanepe.2022.100313. Epub 2022 Jan 26. Lancet Reg Health Eur. 2022. PMID: 35098198 Free PMC article. No abstract available.
-
Impact of COVID-19 on Pregnancy Outcomes: A Phase-Based Analysis from a Spanish Tertiary Hospital (2020-2023).J Clin Med. 2025 Jul 19;14(14):5136. doi: 10.3390/jcm14145136. J Clin Med. 2025. PMID: 40725829 Free PMC article.
-
COVID-19 Infection in Pregnancy: Obstetrical Risk Factors and Neonatal Outcomes-A Monocentric, Single-Cohort Study.Vaccines (Basel). 2022 Jan 21;10(2):166. doi: 10.3390/vaccines10020166. Vaccines (Basel). 2022. PMID: 35214625 Free PMC article.
References
-
- Istituto Superiore di Sanità, Fondazione Bruno Kessler e Ministero della Salute . Prevalenza delle varianti VOC (Variant Of Concern) in Italia: lineage B.1.1.7, P.1, P.2, lineage B.1.351, lineage B.1.525 (Indagine del 18/2/2021) [Presence of Variant Of concern in Italy: lineage B.1.1.7, P.1, P.2, lineage B.1.351, lineage B.1.525 Survey of 18/02/2021]. [Italian] [https://www.epicentro.iss.it/coronavirus/pdf/sars‐cov‐2‐monitoraggio‐var...]. Accessed 29 September 2021.
-
- Istituto Superiore di Sanità, Fondazione Bruno Kessler e Ministero della Salute . Prevalenza delle varianti VOC (Variant Of Concern) in Italia: lineage B.1.1.7, P.1, P.2, lineage B.1.351, lineage B.1.525 (Indagine del 18/3/2021) [Presence of Variant Of concern in Italy: lineage B.1.1.7, P.1, P.2, lineage B.1.351, lineage B.1.525 Survey of 18/03/2021]. [Italian] [https://www.epicentro.iss.it/coronavirus/pdf/sars‐cov‐2‐monitoraggio‐var...]. Accessed 29 September 2021.
-
- Istituto Superiore di Sanità, Fondazione Bruno Kessler e Ministero della Salute . Prevalenza delle varianti VOC (Variant Of Concern) in Italia: lineage B.1.1.7, P.1, P.2, lineage B.1.351, lineage B.1.525 (Indagine del 22/6/2021) [Presence of Variant Of concern in Italy: lineage B.1.1.7, P.1, P.2, lineage B.1.351, lineage B.1.525 Survey of 22/06/2021]. [Italian] [https://www.epicentro.iss.it/coronavirus/pdf/sars‐cov‐2‐monitoraggio‐var...]. Accessed 29 September 2021.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous